Literature DB >> 24457007

Coverage of the English national human papillomavirus (HPV) immunisation programme among 12 to 17 year-old females by area-level deprivation score, England, 2008 to 2011.

A Hughes1, D Mesher, J White, K Soldan.   

Abstract

The English national human papillomavirus (HPV) immunisation programme has offered vaccination to girls aged 12 years at the start of each school year since September 2008. A catch-up programme has offered vaccination to girls up to 18 years. Delivery is predominantly school-based, with some general practitioner (GP)-based immunisation. The relationship between HPV immunisation coverage and deprivation (index of multiple deprivation, IMD) was assessed by geographical area (N=151) for each school year offered the HPV vaccine between 2008 to 2011 using the Spearman’s rank correlation coefficient, and compared to that for adequate cervical screening of women aged 25 to 49 years. Coverage at age 12 showed no significant association with IMD at the area-level (p=0.12). Within the catch-up years, there was some suggestion of higher deprivation being associated with lower coverage. This was not significant for girls offered immunisation under 16 years (in compulsory education) (p=0.09), but was more marked and statistically significant for older girls (p<0.0001). The proportion of women aged 25 to 49 years with an adequate cervical screen was negatively associated with deprivation (p<0.0001). School-based HPV immunisation delivery appears to be successfully reducing inequalities in cervical cancer control at area-level. However, the catch-up cohorts above the age of compulsory education may face increased inequality. Further investigation is needed into individual-level factors associated with coverage.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24457007     DOI: 10.2807/1560-7917.es2014.19.2.20677

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  11 in total

1.  Parents' and providers' attitudes toward school-located provision and school-entry requirements for HPV vaccines.

Authors:  Jessica Vercruysse; Nagasudha L Chigurupati; Leslie Fung; Gauri Apte; Natalie Pierre-Joseph; Rebecca B Perkins
Journal:  Hum Vaccin Immunother       Date:  2016-03-02       Impact factor: 3.452

2.  High-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability Survey.

Authors:  Clare Tanton; Kate Soldan; Simon Beddows; Catherine H Mercer; Jo Waller; Nigel Field; Soazig Clifton; Andrew J Copas; Kavita Panwar; Precious Manyenga; Filomeno da Silva; Kaye Wellings; Catherine A Ison; Anne M Johnson; Pam Sonnenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-03-03       Impact factor: 4.254

3.  Implementation of an HPV vaccination program in Eldoret, Kenya: results from a qualitative assessment by key stakeholders.

Authors:  Heleen Vermandere; Violet Naanyu; Olivier Degomme; Kristien Michielsen
Journal:  BMC Public Health       Date:  2015-09-10       Impact factor: 3.295

4.  Association between human papillomavirus vaccine status and other cervical cancer risk factors.

Authors:  Harriet L Bowyer; Rachael H Dodd; Laura A V Marlow; Jo Waller
Journal:  Vaccine       Date:  2014-06-17       Impact factor: 3.641

5.  Association between mothers' screening uptake and daughters' HPV vaccination: a quasi-experimental study on the effect of an active invitation campaign.

Authors:  Francesco Venturelli; Flavia Baldacchini; Cinzia Campari; Cinzia Perilli; Maria Grazia Pascucci; Alba Carola Finarelli; Luigi Moscara; Paolo Giorgi Rossi
Journal:  BMJ Open       Date:  2017-09-25       Impact factor: 2.692

Review 6.  Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies.

Authors:  Victoria Fernández de Casadevante; Julita Gil Cuesta; Lourdes Cantarero-Arévalo
Journal:  Front Oncol       Date:  2015-06-24       Impact factor: 6.244

7.  Declining genital Warts in young women in england associated with HPV 16/18 vaccination: an ecological study.

Authors:  Rebecca Howell-Jones; Kate Soldan; Sally Wetten; David Mesher; Tim Williams; O Noel Gill; Gwenda Hughes
Journal:  J Infect Dis       Date:  2013-11-01       Impact factor: 5.226

8.  Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data.

Authors:  Megan A Smith; Bette Liu; Peter McIntyre; Robert Menzies; Aditi Dey; Karen Canfell
Journal:  BMC Infect Dis       Date:  2016-02-01       Impact factor: 3.090

9.  Social inequalities and cancer: can the European deprivation index predict patients' difficulties in health care access? a pilot study.

Authors:  Guillaume Moriceau; Aurélie Bourmaud; Fabien Tinquaut; Mathieu Oriol; Jean-Philippe Jacquin; Pierre Fournel; Nicolas Magné; Franck Chauvin
Journal:  Oncotarget       Date:  2016-01-05

10.  Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal).

Authors:  Pam Sonnenberg; Soazig Clifton; Simon Beddows; Nigel Field; Kate Soldan; Clare Tanton; Catherine H Mercer; Filomeno Coelho da Silva; Sarah Alexander; Andrew J Copas; Andrew Phelps; Bob Erens; Philip Prah; Wendy Macdowall; Kaye Wellings; Catherine A Ison; Anne M Johnson
Journal:  Lancet       Date:  2013-11-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.